Statistical Data Scientist

Posted:
12/12/2024, 10:42:46 PM

Location(s):
Maharashtra, India ⋅ Mumbai, Maharashtra, India

Experience Level(s):
Mid Level ⋅ Senior

Field(s):
Data & Analytics

  • Accountable for their assigned work supporting the standards/study deliverables 

  • Contributes to upto 80% of their time to programming deliverables assigned within the scope of the function in either SAS, R or Python and 20% to self learning, development and growth  

  • Review/Develop/Validate datasets, TFL as per CDISC aligned Pfizer Standards or Pfizer Data Standards for Study/Project/Portfolio (TA or Study Programming) 

  • Explore the existing code base and execute/perform runs as required, also develop/modify as per the needs and specifications suggested to the standards team as appropriate – (Standards Programming) 

  • Ensures appropriate documentation and QC across the lifespan of the study for all of their programming deliverables across Standards, Programming and Submissions.  

  • Understand/Develop/Review standard/study/project/portfolio requirements, specifications to gain deeper understanding of expectations and programming requirements, by collaborating with stakeholders.  

  • Knowledgeable in core safety standards as well as TA standards pertinent to their project and lead development of standards necessary for their study 

  • Exhibits routine and occasionally complex problem solving skills, seeking direction when appropriate. 

  • Regularly update leads on progress and time estimations to ensure smooth daily operations and accurate planning 

  • Advances job knowledge to next level by participating/contributing in/to opportunities both globally and locally.  

  
Work Location Assignment: Hybrid

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

Medical

#LI-PFE

Pfizer

Website: https://www.pfizer.com/

Headquarter Location: New York, New York, United States

Employee Count: 10001+

Year Founded: 1849

IPO Status: Public

Last Funding Type: Post-IPO Debt

Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine